Get ready for the 7th Bosnian Turkish Cytopathology School! Join us online on May 27th, 2023 for an exciting and informative event. This School is organized by the Turkish Division of the International Academy of Pathology (TDIAP), Turkish Society of Cytopathology, and Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina.

The focus of the School is on gynecologic cytopathology and will feature renowned and experienced cytopathologists and clinicians from Turkey as lecturers. Their expertise will cover the most crucial topics in gynecologic cytopathology and practical issues, particularly those relevant to young specialists, residents in pathology, and clinicians.

Don't miss out on this exceptional opportunity to expand your knowledge and connect with experts in the field. Over 600 people have already registered, and you don't want to miss out. If you have already registered, there is no need to re-register. However, if you have not yet registered, you can do so for free until May 1st. 

Early registration: until 01 May, 2023.

Specialists/Consultants: free
Residents/Trainees: free
Students: free
 

Late registration: until 25 May, 2023.

Specialists/Consultants: 25 EUR
Residents/Trainees: 20 EUR
Students: 15 EUR

Time is CET

8.30 Opening and introduction

8.50 HPV and Cervical Cancer Epidemiology and Cervical Cancer Screening in Turkey and the World

9.20 Liquid-based Cytology for Cervical Cytology and Automated Screening Devices

10.00 The Bethesda System for Reporting Cervical Cytology

10.40 Non-neoplastic Findings of Cervical Cytology

11.20 Atypical Squamous Cells-Undetermined Significance (ASC-US) and Low Grade Squamous Intraepithelial Lesions (LSIL)

12.00 Lunch

12.30 Atypical Squamous Cells – Cannot Exclude HSIL (ASC-H) and High Grade Squamous Intraepithelial Lesions (HSIL) and Invasive Squamous Cell Carcinoma

13.10 Glandular Cell Abnormalities; Atypical Glandular Cells (AGC), Endocervical AIS and Adenocarcinoma

13.50 Video Microscopy; Case Discussion

15.40 Break

15.55 HPV Testing for Cervical Cancer

16.25 Quality Assurance in Cervical Cytopathology: Why and how?

16.55 Prophylactic HPV Vaccines

17.15 Management of Cervical Premalignant Lesions and Invasive Cervical Cancer

17.45 Discussion and Closing Remarks